Behavior of mild cervical dysplasia during long-term follow-up
- PMID: 3960438
- DOI: 10.1097/00006250-198605000-00012
Behavior of mild cervical dysplasia during long-term follow-up
Abstract
Five hundred and fifty-five women with cervical cytologically diagnosed mild cervical dysplasia were followed by cytology without major treatment. Biopsies were performed in 14% resulting in no significant influence on the outcome of the studied material. Regression to normal occurred in 62% (follow-up 39 months), progression to severe dysplasia/carcinoma in situ/invasive carcinoma in 16% (invasive carcinoma: two patients), and persistence of dysplasia in 22%. Life table analysis calculated the risk of progression of mild dysplasia to be 250 to 800/100,000 women/year. A comparison with the incidence of carcinoma in situ, four of 100,000 women/year, illustrates the yearly risk for a woman with mild dysplasia as 560 times greater than for a woman without cervical dysplasia to develop severe dysplasia/carcinoma in situ/invasive carcinoma.
Similar articles
-
Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.Cancer. 1998 Nov 15;83(10):2150-6. Cancer. 1998. PMID: 9827719
-
Comprehensive cytologic screening in patients undergoing voluntary abortions.Am J Obstet Gynecol. 1974 Jan 1;118(1):102-5. doi: 10.1016/s0002-9378(16)33652-3. Am J Obstet Gynecol. 1974. PMID: 4808862
-
Behavior of moderate cervical dysplasia during long-term follow-up.Obstet Gynecol. 1983 May;61(5):609-14. Obstet Gynecol. 1983. PMID: 6835614
-
[Diagnostic and treatment problems and prospects in precancerous and early stages of cervical cancer].Akush Ginekol (Sofiia). 1981;20(4):331-7. Akush Ginekol (Sofiia). 1981. PMID: 7030097 Review. Bulgarian. No abstract available.
-
[Cytological classifications of vaginal smears. Current concepts of complex cytodiagnosis].Akush Ginekol (Sofiia). 1984;23(4):357-64. Akush Ginekol (Sofiia). 1984. PMID: 6385754 Review. Bulgarian. No abstract available.
Cited by
-
Impact of pentraxin 3 genetic variants on uterine cervical cancer clinicopathologic characteristics.Int J Med Sci. 2021 Apr 7;18(11):2339-2346. doi: 10.7150/ijms.57886. eCollection 2021. Int J Med Sci. 2021. PMID: 33967610 Free PMC article.
-
[Precancerous lesions of the uterine cervix: morphology and molecular pathology].Pathologe. 2011 Nov;32 Suppl 2:242-54. doi: 10.1007/s00292-011-1517-0. Pathologe. 2011. PMID: 21909794 Review. German.
-
VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.BMC Public Health. 2017 Jan 25;17(1):118. doi: 10.1186/s12889-017-4054-9. BMC Public Health. 2017. PMID: 28122530 Free PMC article.
-
Impact of Genetic Variants of Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 on Uterine Cervical Cancer.J Cancer. 2022 Apr 4;13(7):2150-2158. doi: 10.7150/jca.70730. eCollection 2022. J Cancer. 2022. PMID: 35517413 Free PMC article.
-
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.Br J Cancer. 2003 Sep 15;89(6):1062-6. doi: 10.1038/sj.bjc.6601196. Br J Cancer. 2003. PMID: 12966426 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical